2003
DOI: 10.1309/mfrfj0xyjln8nvdp
|View full text |Cite
|
Sign up to set email alerts
|

Endoscopic Ultrasound–Guided Fine-Needle Aspiration

Abstract: Endoscopic ultrasound (EUS) is used to detect and delineate the extent of lesions in the gastrointestinal tract, periluminal lymph nodes, pancreas and hepatobiliary tree, left kidney, spleen, and adrenal glands. EUS-guided fine-needle aspiration (FNA) has added a new dimension to the capabilities of EUS because it permits characterization of the lesion, thereby enabling triage of patients for more efficient and effective management. This review focuses on the advantages and limitations of EUS-FNA, including a … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
148
0
7

Year Published

2004
2004
2021
2021

Publication Types

Select...
7
3

Relationship

2
8

Authors

Journals

citations
Cited by 208 publications
(161 citation statements)
references
References 0 publications
6
148
0
7
Order By: Relevance
“…Afterwards, an endoscopic fine needle aspiration biopsy was performed. This approach is consistent with literature which has shown that not only endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) has dramatically improved our ability to sample pancreatic solid lesions (6), but also that EUS-FNA is a safe and accurate method in evaluating pancreatic masses, especially in the presence of an on-site cytopathologist who can provide a real-time determination of whether a specimen is adequate or additional samples are necessary (7)(8)(9). Other studies however, have shown that CT guided biopsy may also be an option (10).…”
Section: Discussionsupporting
confidence: 87%
“…Afterwards, an endoscopic fine needle aspiration biopsy was performed. This approach is consistent with literature which has shown that not only endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) has dramatically improved our ability to sample pancreatic solid lesions (6), but also that EUS-FNA is a safe and accurate method in evaluating pancreatic masses, especially in the presence of an on-site cytopathologist who can provide a real-time determination of whether a specimen is adequate or additional samples are necessary (7)(8)(9). Other studies however, have shown that CT guided biopsy may also be an option (10).…”
Section: Discussionsupporting
confidence: 87%
“…Conventional EUS-FNA has certain limitations. Sensitivity significantly decreases by 10-15 % without an on-site pathologist to evaluate the sample obtained during the procedure (40)(41)(42). Without on-site evaluation, the recommended number of passes is 5-7 for solid pancreatic lesions and 2-3 for lymph nodes (34,40,41).…”
Section: Discussionmentioning
confidence: 99%
“…In previous studies showing high diagnostic yields of cytology, 3 to 6 needle passes through the lesion [16][17][18][19][20][21][22][23]26] and on-site evaluation of the FNA sample adequacy by a cytopathologist [10,[27][28][29] was considered essential. We were able to obtain an adequate sample in 90% of cases by performing three passes, two for cytological evaluation and one for histological evaluation.…”
Section: Discussionmentioning
confidence: 99%